It is also produced by fallopian tube and uterine cells and G-CSF receptors have been identified on the surface of egg cells. These findings prompted investigations that have shown its use to be of benefit in the treatment of implantation failure following IVF, recurrent miscarriage and poor development of the lining of the uterus during assisted reproduction treatment cycles that is resistant to other treatments.
Clinical trials using G-CSF as a treatment for thin endometrium have reported a clinically significant effect within 48 hours of administration. At Fertility North, we offer a form of G-CSF called Nivestim™ at a dosage that has been shown in clinical trials to be beneficial.
Book an Appointment: (08) 9301 1075
Call us: 8.30am - 4:00pm
Email: admin@fertilitynorth.com.au